Impact of pulmonary vein-first ligation during lobectomy on the postoperative survival and recurrence rates in patients with non-small cell lung cancer: a multicenter propensity score-matched study
- Haruhiko Shiiya 1, Hideki Ujiie 1, Ryohei Chiba 1, Shunsuke Nomura 1, Kazuto Ohtaka 1, Aki Fujiwara-Kuroda 1, Masato Aragaki 1, Keita Takahashi 2, Kazufumi Okada 2, Tatsuya Kato 3
- Haruhiko Shiiya 1, Hideki Ujiie 1, Ryohei Chiba 1
- 1Department of Thoracic Surgery, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
- 2Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan.
- 3Department of Thoracic Surgery, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan. katotatu@huhp.hokudai.ac.jp.
- 0Department of Thoracic Surgery, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ligating the pulmonary vein first during lung cancer lobectomy significantly improves patient survival and reduces recurrence rates. This technique enhances outcomes for non-small cell lung cancer patients undergoing surgery.
Area Of Science
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background
- Surgical manipulation during lung cancer lobectomy can increase circulating tumor cells, raising metastasis risk.
- Optimizing surgical techniques is crucial for improving patient prognosis in lung cancer treatment.
Purpose Of The Study
- To investigate the impact of ligating the tumor-draining pulmonary vein first during lobectomy on lung cancer patient prognosis.
- To determine if a "vein-first" approach improves survival and recurrence rates compared to conventional methods.
Main Methods
- Retrospective evaluation of patients undergoing curative lobectomy for solitary non-small cell lung carcinoma (2012-2016).
- Patients were divided into a "vein-first" group (pulmonary veins ligated before artery/bronchus) and an "other procedure" group.
- Propensity score matching was used to create comparable patient cohorts for analysis.
Main Results
- The vein-first group demonstrated significantly better 5-year overall survival (85.6% vs. 69.4%) and recurrence-free survival (73.4% vs. 53.5%).
- The cumulative recurrence rate at 5 years post-surgery was significantly lower in the vein-first group (21.7% vs. 38.3%).
- These improvements were observed after propensity score matching, indicating the technique's efficacy.
Conclusions
- Ligating the pulmonary vein first during lung cancer lobectomy is associated with improved overall survival and recurrence-free survival.
- This surgical approach may reduce the cumulative recurrence rate in non-small cell lung cancer patients.
- The "vein-first" technique represents a promising strategy for enhancing surgical outcomes in lung cancer treatment.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

